Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,209.01
+1.0%
+73.06
Arrow-Thin-Down
DJI
49,652.14
+1.6%
+790.33
Arrow-Thin-Down
NASDAQ
24,892.31
+0.9%
+219.07
Arrow-Thin-Down
Bitcoin
$77,128.00
+1.4%
+$1,072.48
Arrow-Thin-Down
AAPL
$270.97
+0.3%
+$0.80
Arrow-Thin-Down
AMZN
$265.03
+0.8%
+$1.99
Arrow-Thin-Down
GOOG
$381.94
+10.0%
+$34.63
Arrow-Thin-Down
META
$612.31
-8.5%
-$56.81
Arrow-Thin-Down
MSFT
$407.91
-3.9%
-$16.55
Arrow-Thin-Down
NVDA
$199.57
-4.6%
-$9.68
Arrow-Thin-Down
TSLA
$381.63
+2.4%
+$8.83
Most Active StocksDaily Stock GainersDaily Stock Losers
Invion logo

Invion

(ASX) IVX

Current Price$0.06
Market Cap$6.01M
Since IPO (2010)-100%
5 YearN/A
1 Year-38%
1 Month-11%

Invion Financials at a Glance

Market Cap

$6.01M

Revenue (TTM)

$1.47M

Net Income (TTM)

$17.29M

EPS (TTM)

$-0.14

P/E Ratio

-0.46

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.06

Volume

78,246

Open

$0.06

Previous Close

$0.06

Daily Range

$0.06 - $0.06

52-Week Range

$0.06 - $0.20

IVX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Invion

Industry

Pharmaceuticals

Sector

Health Care

CEO

Thian Chew, MBA

Website

www.inviongroup.com

Headquarters

Melbourne, VIC 3205, AU

IVX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-112%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-2.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.01M

Shares Outstanding

96.97M

Volume

78.25K

Avg. Volume

100.08K

Financials (TTM)

Gross Profit

$1.29M

Operating Income

$5.29M

EBITDA

$4.00M

Operating Cash Flow

$2.97M

Capital Expenditure

$0.00

Free Cash Flow

$2.97M

Cash & ST Invst.

$850.37K

Total Debt

$0.00

Invion Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$859.57K

-232.8%

Gross Margin

0.00%

N/A

Market Cap

$6.01M

N/A

Market Cap/Employee

$751.48K

N/A

Employees

8

N/A

Net Income

$3.57M

-399.3%

EBITDA

$2.62M

-648.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$490.14K

-125.3%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$627.68K

N/A

Return on Assets

-1.30%

N/A

Return on Invested Capital

-1.18%

N/A

Free Cash Flow

$1.27M

+40.8%

Operating Cash Flow

$1.27M

-2.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VBS.AXVectus Biosystems Limited
$0.11-8.33%
HIQ.AXHITIQ Limited
$0.01+0.00%
PER.AXPercheron Therapeutics Limited
$0.01+11.11%
IRX.AXInhaleRx Limited
$0.03+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$199.98-0.04%
GOOGLAlphabet
$385.15+0.10%
METAMeta Platforms
$612.31-0.08%
MSFTMicrosoft
$407.91-0.04%

Questions About IVX

What is the current price of Invion?

Invion is trading at A$0.06 per share.

What is the 52-week range for Invion?

Over the past 52 weeks, Invion has traded between A$0.06 and A$0.20.

How much debt does Invion have?

As of the most recent reporting period, Invion reported total debt of N/A.

How much cash does Invion have on hand?

Invion reported $850,373 in cash and cash equivalents in its most recent financial results.

What is Invion’s dividend yield?

Invion does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services